| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0142-9612(96)00146-9 |
| P698 | PubMed publication ID | 9068888 |
| P2093 | author name string | C Sternberg | |
| A M Fischer | |||
| H Sahli | |||
| D Labarre | |||
| J Tapon-Bretaudière | |||
| G Spenlehauer | |||
| T Verrecchia | |||
| P2860 | cites work | Biodegradable long-circulating polymeric nanospheres | Q38569096 |
| A method for the estimation of polyethylene glycol in plasma protein fractions | Q71387757 | ||
| Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators | Q71616818 | ||
| Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System | Q71943642 | ||
| Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies | Q72902854 | ||
| P433 | issue | 4 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 281-288 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system | |
| P478 | volume | 18 |
| Q39620217 | CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility |
| Q77205963 | Comparison of the biodistribution in mice of 111indium oxine encapsulated into poly(lactic-co-glycolic)-D,L-85/15 and poly(epsilon caprolactone) nanocapsules |
| Q53621771 | Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. |
| Q46308403 | Complex encounters: nanoparticles in whole blood and their uptake into different types of white blood cells |
| Q43569886 | Design of rolipram-loaded nanoparticles: comparison of two preparation methods |
| Q38089879 | Designing PEGylated therapeutic molecules: advantages in ADMET properties |
| Q50516003 | Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging. |
| Q33985140 | Drug transport to brain with targeted nanoparticles |
| Q57677379 | Formulation of therapeutic synthetic polymers for drug and gene delivery ▾ |
| Q39396607 | Hemocompatibility and macrophage response of pristine and functionalized graphene |
| Q74266239 | Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system |
| Q41470605 | Intravenous hemostat: nanotechnology to halt bleeding. |
| Q74830469 | Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) |
| Q28655569 | Nanoparticles from renewable polymers |
| Q36604526 | Pharmacokinetic consequences of pegylation |
| Q43632909 | Preparation of nanoparticles composed with bioinspired 2-methacryloyloxyethyl phosphorylcholine polymer |
| Q40862339 | Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). |
| Q44144588 | Synthesis of pegylated immunonanoparticles |
| Q60775760 | ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption |
Search more.